Search Results - "EBERLING, J. L"
-
1
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
Published in Neurology (17-11-2009)“…In Parkinson disease (PD), the benefit of levodopa therapy becomes less marked over time, perhaps because degeneration of nigrostrial neurons causes…”
Get full text
Journal Article -
2
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
Published in Neurology (20-05-2008)“…In a primate model of Parkinson disease (PD), intrastriatal infusion of an adeno-associated viral (AAV) vector containing the human aromatic l-amino acid…”
Get full text
Journal Article -
3
Preliminary evidence that estrogen protects against age-related hippocampal atrophy
Published in Neurobiology of aging (01-09-2003)“…Few studies have examined gender differences in hippocampal volumes, and the potential effect of estrogen on these measures has not been well studied. We used…”
Get full text
Journal Article -
4
Brain structure and cognition in a community sample of elderly latinos
Published in Neurology (13-08-2002)“…Previous studies have found that hippocampal atrophy and white matter hyperintensities (WMH) on MRI are linked to cognitive impairment and dementia. The…”
Get full text
Journal Article -
5
Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug Approach
Published in Experimental neurology (01-07-2000)“…Using an approach that combines gene therapy with aromatic l-amino acid decarboxylase (AADC) gene and a pro-drug (l-dopa), dopamine, the neurotransmitter…”
Get full text
Journal Article -
6
Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease
Published in Annals of neurology (01-09-2000)“…Patients with extensive subcortical cerebrovascular disease may have impaired memory, often despite the absence of medial temporal or diencephalic strokes. In…”
Get full text
Journal Article -
7
Effect of estrogen on cerebral glucose metabolism in postmenopausal women
Published in Neurology (26-09-2000)“…PET was used to evaluate the effect of estrogen use on regional cerebral glucose metabolism in postmenopausal women. Women receiving estrogen replacement…”
Get full text
Journal Article -
8
Brain function and cognition in a community sample of elderly latinos
Published in Neurology (13-08-2002)“…Previous studies using PET to measure cerebral glucose metabolism in AD have found metabolic reductions in the temporoparietal and posterior cingulate cortices…”
Get full text
Journal Article -
9
Tremor Is Associated with PET Measures of Nigrostriatal Dopamine Function in MPTP-Lesioned Monkeys
Published in Experimental neurology (01-10-2000)“…Unilateral intracarotid artery (ICA) MPTP infusion, along with sequential systemic doses of MPTP, produces near complete degeneration of the nigrostriatal…”
Get full text
Journal Article -
10
PET studies of functional compensation in a primate model of Parkinsonʼs disease
Published in Neuroreport (18-08-1997)“…MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a neurotoxin that produces degeneration of nigrostriatal dopaminergic neurons and a chronic parkinsonian…”
Get full text
Journal Article -
11
In vivo PET imaging of gene expression in parkinsonian monkeys
Published in Molecular therapy (01-12-2003)Get full text
Journal Article -
12
Reduced temporal lobe blood flow in Alzheimer's disease
Published in Neurobiology of aging (01-07-1992)“…We used single photon emission computed tomography with the blood flow tracer [123I]N-isopropyl-p-iodoamphetamine (IMP) to study regional cerebral blood flow…”
Get more information
Journal Article -
13
Cerebral Glucose Metabolism and Memory in Aged Rhesus Macaques
Published in Neurobiology of aging (01-07-1997)“…Positron emission tomography and the glucose metabolic tracer [ 18F]fluorodeoxyglucose were used to evaluate the relationship between regional cerebral…”
Get full text
Journal Article -
14
A methodology for specifying PET VOIs using multimodality techniques
Published in IEEE transactions on medical imaging (01-08-1997)“…Volume-of-interest (VOI) extraction for radionuclide and anatomical measurements requires correct identification and delineation of the anatomical feature…”
Get full text
Journal Article -
15
A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes
Published in Brain research (14-09-1998)“…Positron emission tomography (PET) and the dopamine (DA) metabolism tracer, [ 18 F] 6-fluoro- l- m-tyrosine (FMT) were used to evaluate the relationship…”
Get full text
Journal Article -
16
Brain perfusion imaging predicts survival in Alzheimer's disease
Published in Neurology (01-10-1998)“…The variability of disease course in patients diagnosed with AD makes prediction of survival difficult, despite the identification of numerous predictors to…”
Get full text
Journal Article -
17
Cortical glucose metabolism in Parkinson's disease without dementia
Published in Neurobiology of aging (01-05-1994)“…There have been several reports of decreased regional cerebral metabolic rates for glucose (rCMRglc) in Parkinson's disease (PD), although others find no…”
Get more information
Journal Article -
18
Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study
Published in Neurobiology of aging (01-07-1994)“…The involvement of the corpus callosum in aging and Alzheimer's disease (AD) is not clear. We measured cross sectional areas of the entire corpus callosum…”
Get more information
Journal Article -
19
Iodine-123-5-Iodo-6-Nitroquipazine: SPECT Radiotracer to Image the Serotonin Transporter
Published in The Journal of nuclear medicine (1978) (01-07-1996)“…Because serotonergic function has been implicated in the pathophysiology of a number of diseases of the nervous system, efforts to image this system in vivo…”
Get full text
Journal Article -
20
Dopamine transporter loss and clinical changes in MPTP-lesioned primates
Published in Brain research (19-06-1999)“…Single photon emission computed tomography (SPECT) and the dopamine (DA) transporter tracer, 2 beta-carboxymethoxy-3 beta-(4-iodophenyl)tropane ([123I]β-CIT),…”
Get full text
Journal Article